about
Guideline for collection, analysis and presentation of safety data in clinical trials of vaccines in pregnant womenImpact, challenges, and future projections of vaccine trials in AfricaEffectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh.Non-reassuring fetal status: Case definition & guidelines for data collection, analysis, and presentation of immunization safety dataMaternal death: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.Postpartum haemorrhage: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataCongenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataNeonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.Pathways to preterm birth: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataPreterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data.Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteersSpontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases.Hypertensive disorders of pregnancy: Case definitions & guidelines for data collection, analysis, and presentation of immunization safety data.Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Template protocol for clinical trials investigating vaccines--focus on safety elementsAdventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysisGuidance for the collection of case report form variables to assess safety in clinical trials of vaccines in pregnancy.Safety reporting in developing country vaccine clinical trials-a systematic review.Introducing new vaccines in developing countries.Standardization and simplification of vaccination records.Immunization in pregnancy clinical research in low- and middle-income countries - Study design, regulatory and safety considerations.Global alignment of immunization safety assessment in pregnancy - The GAIA project.The importance of the patient voice in vaccination and vaccine safety-are we listening?Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.Scientific challenges and opportunities in developing novel vaccines for the emerging and developing markets: New Technologies in Emerging Markets, October 16th-18th 2012, World Vaccine Congress, LyonChallenges and impact of conducting vaccine trials in Asia and Africa: New Technologies in Emerging Markets, October 16th-18th 2012; World Vaccine Congress, Lyon.Global lessons from Nigeria's ebolavirus control strategy.A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.P14-01. Care and treatment for volunteers in IAVI-sponsored HIV vaccine clinical trials in India.Respiratory distress in the neonate: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.Neonatal encephalopathy: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.Dysfunctional labor: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.Prioritizing polio.Safety assessment of immunization in pregnancy.Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Low birth weight: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data.
P50
Q26250281-C8915704-553E-437B-A014-814F0C2496A7Q27012771-3F0CC1C2-43CC-49E6-A8BE-5454271001EFQ28550474-7D8F4745-0394-43BF-A000-9B047EEEE349Q30276269-091CCCB6-E4EA-477B-AA38-4031F0691EDBQ30380075-9656CA3F-68F1-4627-8DDA-C9FC67499AB6Q31115556-71A7819A-37E2-4705-8420-504990049587Q31115558-9CB55A2F-F342-4029-9391-644FBE6C7169Q31115877-C4A81900-193E-4B7C-A2AF-0745EEDD4AE3Q31119651-C6B24342-7CE2-45D0-A247-721B7CAD2A52Q31119656-DBC9D2E4-A802-40A5-B556-1DA3FC0D04D8Q31136863-7C2C495B-DE52-40E6-BF2B-BAA7913DC3F8Q34589611-811D907C-D764-4659-A8E1-CE5C06227C01Q35782657-6A28C342-6B51-45DE-A5CA-2800B08394AAQ36079659-25924621-C54E-4D0D-9110-87EB7BC2A724Q36083608-A469817E-599E-4E6C-B6ED-0514827FC7EAQ36100736-400D74DA-1D67-4D82-A44B-05841F174FACQ37458983-49B37ED6-EE5A-4EAA-9CFD-A263866411DBQ37477687-1831992B-096F-4D19-B28B-4D82232D4358Q37992392-95E1A8A6-748C-4FF3-A156-7D008A4E208EQ38160253-AED2D8CF-8F96-4775-A07B-0B73F7B513D0Q38193522-C0F18194-49EE-473A-AF85-4DA9693D3B77Q38370917-73A8D38E-FF85-4B88-9A8F-898273F8F19CQ38441751-2549C268-0250-4A8A-A3B4-34FAADE0216FQ39113525-C58CE539-AD11-47F6-8CEE-3D67BF8A50CDQ39437108-86EBA3CD-06A0-4215-A103-88541C09DE31Q40619713-F8FD8C9C-9C3F-4869-A948-43E71DC653FAQ42733080-B9738812-B27F-43B2-A2DA-DACAEA09D2ECQ42733082-D3DE704F-4F25-4D78-81C9-ECBC6514CA1CQ44099581-CC8AB1C2-3608-482B-B24A-B85C52902D8AQ44590524-C16E0E6E-E03E-479D-AD07-0FE8D4468891Q45394526-DD94CE7F-7C81-4DAD-A599-28BBCD7B2807Q45839934-1840D8B4-B991-4CD5-AED7-823946D136E7Q46162864-5F5D99C6-73AB-4EF4-AB7D-F2C0D7827185Q46204396-8799E791-CB41-4BDB-A9F7-11FFE23B52ADQ46489520-090F0DDE-FABF-45BF-AE8E-90EA93322CA9Q46639978-1AD87BC1-C2BB-41E3-8FB8-EBB67A0B5BD4Q46892437-706BB3EA-2BFD-4FA9-A166-C4EF419B2EB9Q47098778-820DD1DE-20C6-41E4-8D36-67E9D34C2C97Q47105351-FAE513B6-8241-4C63-BA8C-CE5854AB50C0Q47106348-4F72A048-32D2-4795-BA71-39DAF239F437
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sonali Kochhar
@ast
Sonali Kochhar
@en
Sonali Kochhar
@es
Sonali Kochhar
@nl
Sonali Kochhar
@sl
type
label
Sonali Kochhar
@ast
Sonali Kochhar
@en
Sonali Kochhar
@es
Sonali Kochhar
@nl
Sonali Kochhar
@sl
prefLabel
Sonali Kochhar
@ast
Sonali Kochhar
@en
Sonali Kochhar
@es
Sonali Kochhar
@nl
Sonali Kochhar
@sl
P106
P21
P31
P496
0000-0002-1150-5691